Back

Feasibility of slow pathway modulation using a dual-energy lattice-tip catheter

12 April 2026 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Ablation of supraventricular tachycardias Treatment EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Emanuele Chiarazzo

Tor Vergata University Hospital Polyclinic, Rome (Italy)

6 More presentations in this session

Presentation thumbnail
High-frequency areas identified by omnipolar technology near-field mapping as a precise landmark for successful accessory pathway ablation
Doctor T. Kanda (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
A standardized low-fluoro approach to perform atrio-ventricular nodal re-entrant tachycardia ablation. PICENO AVNRT.
Doctor P. Marchese (Ascoli Piceno, IT)
Abstract Slides Video
Presentation thumbnail
Catheter ablation for atrial tachycardia is associated with lower risks of mortality, stroke and cardiovascular hospitalization than electrocardioversion
Doctor A. Kahle (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Ten-year outcomes after slow pathway modulation for AVNRT: insights from a large real-world cohort
Doctor R. Wahedi (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Electrophysiological features and catheter ablation of supraventricular tachyarrhythmias in patients with Fontan circulation: nationwide multicenter study
Associate Professor J. Uhm (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Ablation of supraventricular tachycardias

The Event

Event poster

EHRA 2026

12 April 2026 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Dual-energy lattice-tip ablation system for atrial fibrillation: acute results from the Affera Global Registry
thumbnail
Congress Presentation
Pulsed field ablation of the coronary sinus and mitral isthmus with the lattice-tip catheter: promising acute results, uncertain durability
thumbnail
Congress Presentation
Focal pulsed field ablation in right atrial tachycardia -initial clinical experience-

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources